Direct oral anticoagulants (DOACs; factor Xa inhibitors) such as apixaban and rivaroxaban have shown worse outcomes compared to warfarin as seen in the ASTRO-APS study [1,9]. This evidence concerns the gene F10 and autoimmune polyendocrinopathy.